Effect Modification between Genes and Environment and Parkinson's Disease Risk.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
11 2022
Historique:
revised: 26 07 2022
received: 07 03 2022
accepted: 28 07 2022
pubmed: 2 8 2022
medline: 26 10 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

Parkinson's disease (PD) is a complex neurodegenerative condition in which genetic and environmental factors interact to contribute to its etiology. Remarkable progress has been made in deciphering disease etiology through genetic approaches, but there is limited data about how environmental and genetic factors interact to modify penetrance, risk, and disease severity. Here, we provide insights into environmental modifiers of PD, discussing precedents from other neurological and non-neurological conditions. Based on these examples, we outline genetic and environmental factors contributing to PD and review potential environmental modifiers of penetrance and clinical variability in monogenic and idiopathic PD. We also highlight the potential challenges and propose how future studies might tackle these important questions. ANN NEUROL 2022;92:715-724.

Identifiants

pubmed: 35913124
doi: 10.1002/ana.26467
pmc: PMC9588606
mid: NIHMS1827195
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

715-724

Subventions

Organisme : NIA NIH HHS
ID : K24 AG000949
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 AG000949
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 AG999999
Pays : United States

Informations de copyright

© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

PLoS Med. 2017 Jun 13;14(6):e1002314
pubmed: 28609445
Ann Am Thorac Soc. 2021 Feb;18(2):215-217
pubmed: 33522873
Orphanet J Rare Dis. 2018 Jun 26;13(1):101
pubmed: 29941009
Neurology. 2020 Dec 15;95(24):e3428-e3437
pubmed: 32999056
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Mov Disord. 2021 Jun;36(6):1420-1429
pubmed: 33682937
Neurology. 2018 Feb 13;90(7):e583-e592
pubmed: 29352099
Mov Disord. 2021 Apr;36(4):842-851
pubmed: 33513272
PLoS One. 2015 Jun 29;10(6):e0131778
pubmed: 26121579
Front Aging Neurosci. 2018 Sep 19;10:283
pubmed: 30283330
Hum Genet. 2013 Oct;132(10):1077-130
pubmed: 23820649
Neurology. 2012 Feb 7;78(6):417-20
pubmed: 22282650
Genet Med. 2013 Feb;15(2):146-9
pubmed: 22935721
J Parkinsons Dis. 2021;11(1):31-43
pubmed: 33361610
Int J Epidemiol. 2005 Dec;34(6):1243-9
pubmed: 16131516
Parkinsonism Relat Disord. 2012 Mar;18(3):263-7
pubmed: 22100523
Ann Neurol. 2006 Feb;59(2):298-309
pubmed: 16358335
Brain. 2003 Sep;126(Pt 9):2074-80
pubmed: 12821514
JAMA. 2008 Jan 30;299(4):417-24
pubmed: 18230779
NPJ Parkinsons Dis. 2019 Mar 27;5:4
pubmed: 30937360
Neuroepidemiology. 2016;46(4):292-300
pubmed: 27105081
Ann Neurol. 2021 Jul;90(1):22-34
pubmed: 33583074
Adv Neurol. 2004;94:121-5
pubmed: 14509664
Genet Med. 2014 Feb;16(2):188-200
pubmed: 24385074
Int J Epidemiol. 2020 Apr 1;49(2):435-447
pubmed: 31722376
Neuropsychology. 2021 Jul 29;:
pubmed: 34323564
J Clin Invest. 1999 Aug;104(4):431-7
pubmed: 10449435
Breast Cancer Res. 2012 Mar 09;14(2):R42
pubmed: 22405187
Lancet. 2021 Jun 12;397(10291):2284-2303
pubmed: 33848468
J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):853-4
pubmed: 22577228
Genomics. 1999 Dec 15;62(3):377-84
pubmed: 10644435
Acta Neurol Scand. 2022 May;145(5):504-528
pubmed: 34997759
Brain Sci. 2022 Jan 28;12(2):
pubmed: 35203939
BMC Neurol. 2018 Nov 5;18(1):184
pubmed: 30396335
Eur J Hum Genet. 2017 May;25(5):608-616
pubmed: 28198392
Neurosci Lett. 2020 Jan 10;715:134609
pubmed: 31698024
Pediatr Res. 2019 Jan;85(2):242-250
pubmed: 30333522
Neurobiol Dis. 2020 Apr;137:104782
pubmed: 31991247
Genes (Basel). 2021 Jun 30;12(7):
pubmed: 34208795
Mov Disord. 2008 Jul 15;23(9):1228-33
pubmed: 18464276
Parkinsonism Relat Disord. 2015 Jul;21(7):778-82
pubmed: 25962553
Neurotoxicology. 2012 Oct;33(5):947-71
pubmed: 22627180
Inflamm Bowel Dis. 2019 Jan 1;25(1):111-123
pubmed: 29788069
JAMA Neurol. 2020 Feb 1;77(2):192-198
pubmed: 31609378
Toxicol Appl Pharmacol. 2013 Feb 1;266(3):345-55
pubmed: 23220449
Mov Disord. 2020 Oct;35(10):1854-1858
pubmed: 32875616
Nat Rev Dis Primers. 2021 May 20;7(1):36
pubmed: 34017006
Nat Commun. 2021 Feb 17;12(1):1078
pubmed: 33597508
Acta Neurol Scand. 2020 Nov;142(5):443-448
pubmed: 32484913
Mov Disord. 2020 Oct;35(10):1755-1764
pubmed: 32662532
PLoS One. 2015 Mar 27;10(3):e0120189
pubmed: 25816289
Ann Neurol. 2012 Jan;71(1):40-8
pubmed: 22275250
Mov Disord. 2013 Dec;28(14):1966-71
pubmed: 24243757
Ann Neurol. 2019 Apr;85(4):593-599
pubmed: 30761591
Neurology. 2015 Mar 3;84(9):880-7
pubmed: 25653295
J Parkinsons Dis. 2021;11(3):919-935
pubmed: 33814465
Ann Clin Transl Neurol. 2017 Oct 19;4(11):801-810
pubmed: 29159192
Eur J Epidemiol. 2014 Sep;29(9):613-9
pubmed: 24894826
Neurology. 2007 Oct 16;69(16):1595-602
pubmed: 17938369
Breast Cancer Res Treat. 2014 Feb;143(3):579-86
pubmed: 24458845
J Parkinsons Dis. 2020;10(3):1123-1132
pubmed: 32310186
Breast Cancer Res. 2005;7(5):R833-43
pubmed: 16168130
Am J Respir Crit Care Med. 2000 Dec;162(6):2172-6
pubmed: 11112133
JAMA Netw Open. 2018 Sep 7;1(5):e182421
pubmed: 30646166
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1137-43
pubmed: 20581166
Lancet Neurol. 2008 Jul;7(7):583-90
pubmed: 18539534
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888
pubmed: 22315721
JAMA Neurol. 2014 Jun;71(6):752-7
pubmed: 24756352
J Natl Cancer Inst. 2014 Jun;106(6):dju091
pubmed: 24824314
J Neurol. 2013 Apr;260(4):1081-6
pubmed: 23212755
J Neurosci. 2010 May 5;30(18):6355-9
pubmed: 20445061
Neurol Sci. 2015 Dec;36(12):2269-75
pubmed: 26265293
Sci Rep. 2015 Nov 02;5:15492
pubmed: 26522888
Mol Genet Metab. 2011;104 Suppl:S26-30
pubmed: 21944883
Environ Health Perspect. 2016 Mar;124(3):351-6
pubmed: 26151951
Front Neurol. 2021 Apr 06;12:648417
pubmed: 33889126
Mech Ageing Dev. 2018 Jul;173:1-8
pubmed: 29630901
Mov Disord. 2020 Nov;35(11):2111-2114
pubmed: 32767585
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Sci Rep. 2018 Nov 8;8(1):16525
pubmed: 30410011
Am J Hum Genet. 2020 Aug 6;107(2):234-250
pubmed: 32668217
J Parkinsons Dis. 2019;9(3):501-515
pubmed: 31282427
Neurol Genet. 2020 Oct 20;6(6):e523
pubmed: 33209983
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):871-8
pubmed: 26848171
Mov Disord. 2021 Jun;36(6):1353-1361
pubmed: 33405293
J Parkinsons Dis. 2020;10(4):1649-1656
pubmed: 32716321
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1046-1054
pubmed: 32934108
Curr Dir Psychol Sci. 2009 Feb 1;18(1):48
pubmed: 20126294
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477
pubmed: 30564614
Neurology. 2015 Jul 7;85(1):89-95
pubmed: 26062626
JAMA Neurol. 2014 Dec;71(12):1535-9
pubmed: 25330418
Ann Neurol. 2021 Jul;90(1):35-42
pubmed: 33901317
JAMA Neurol. 2020 Aug 1;77(8):1034-1035
pubmed: 32391853
N Engl J Med. 1983 Aug 4;309(5):310
pubmed: 6602944
Mol Genet Metab. 2019 Sep - Oct;128(1-2):53-56
pubmed: 31208951
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:201-222
pubmed: 29709203
NPJ Parkinsons Dis. 2015;1:
pubmed: 27148593
Environ Health Perspect. 2011 Jun;119(6):866-72
pubmed: 21269927
Adv Exp Med Biol. 2017;978:363-390
pubmed: 28523556
Mov Disord. 2002 Mar;17(2):339-45
pubmed: 11921121
Neurobiol Aging. 2012 Oct;33(10):2528.e1-6
pubmed: 22763023

Auteurs

Maria Teresa Periñán (MT)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Madrid, Spain.

Kajsa Brolin (K)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund, Sweden.

Sara Bandres-Ciga (S)

Laboratory of Neurogenetics, Molecular Genetics Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

Cornelis Blauwendraat (C)

Laboratory of Neurogenetics, Molecular Genetics Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

Christine Klein (C)

Institute of Neurogenetics and Department of Neurology, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck, Germany.

Ziv Gan-Or (Z)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

Andrew Singleton (A)

Laboratory of Neurogenetics, Molecular Genetics Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

Pilar Gomez-Garre (P)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Madrid, Spain.

Maria Swanberg (M)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund, Sweden.

Pablo Mir (P)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Madrid, Spain.

Alastair Noyce (A)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH